神经调节如何改变了手术的风景?
Tatiana von Hertwig Fernandes de Oliveira1, Arthur Cukiert2
1Hospital Universita´rio Cajuru, Curitiba, Brazil.
Stereotactic and functional neurosurgery
|September 24, 2025
概括
神经调节疗法,如迷走神经刺激 (VNS),深度大脑刺激 (DBS) 和响应性神经刺激 (RNS),为抗药性提供了希望. 虽然有效,但优化设备选择和刺激参数需要进一步研究以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
背景情况:
- 影响全球数以百万计的人,其中很大一部分对传统抗药物有抗性.
- 耐药性是一个巨大的挑战,需要替代治疗策略.
- 神经调节为治疗耐火性提供了一种可行的方法,减少了患者的负担.
研究的目的:
- 审查目前用于抗药性的神经调节技术的现状.
- 讨论VNS,DBS和RNS的机制,应用和比较方面.
- 强调在神经调节治疗中需要精细的临床决策.
主要方法:
- 对VNS,DBS和RNS的实验证据和临床数据的审查.
- 对中神经调节的分子,细胞和网络层次机制的分析.
- 对不同神经调节器件的指示,益处和缺点进行比较评估.
主要成果:
- VNS,DBS和RNS在调节大脑电路和减少活动方面表现出有效性.
- 这些技术通过各种机制减少神经元的超同步.
- 目前的证据支持神经调节在特定病例中的安全性和有效性.
结论:
- 神经调节是治疗耐药性的有希望的途径.
- 进一步的研究至关重要,以确定设备选择,目标识别和参数优化的明确标准.
- 对VNS,DBS和RNS的持续调查将完善治疗策略并改善患者的治疗结果.
相关概念视频
Psychosurgery
1.5K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
1.5K
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
827
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
827


